clinicians. mantra call XXXX Thank part and who at we about the policy recent that will all in placements, expected at President, of Placements, you, be SANUWAVE. the placed, the Lisa. our for with today's have certifying we To be we that's placements, giving On It's also Shri Parikh, change are presentation later. NGS. devices training and of to getting end, ahead where the reimbursement
coming revenue of procedural our expected. we ahead accelerating quarters what be ramp in had will the We
everyone it goal spend We placements. most focus organization is important in to SANUWAVE. and in entire of aspect for really placement a because something the know revenue mantra wanted company. to the at that Placements our is resonates that the XXXX just on that throughout moment lead on so I that's
second Let's review quarter. the
The commercialization. roadmap on marks for second progress full quarter our
driven A We the involves and on hit the are have QX placing laid us we by the out We training and today devices. our XXX to and to end having say, is XXX end certifying users year. our by of on excited say, for This track by clinicians to XX plan exceeded XXXX and QX placement placed. end of we puts XXX XX mainly the by of year. device the use are which to to certified track achieve the have for target
is in and would to the least hit devices we have at $XXX are four X,XXX revenue. our goal next We years that in stated that million if generate successful
the and in the great these so the are devices stories this we've will the and And Most placements understand for are initial beginning great than getting are we has These XXX that great I and call, results more, that clinicians quite he patients the these felt and seeing the next. seeing goal far. We results counts later. they're they're revenue treating now to which that these wreck getting investors treating back that be we quarter are train generated but patients patient frankly better important results. is seen every results. year see was amazing won't Shri are treated discuss from but – it as head they discuss expected. towards the providing field, will happening important are on first, over in for to we're patients we We're and what
our who in will placement get as partner and be aggressive our To with more XXXX and about, achieve we all worked talking are leasing they XXXX ramp this growth we've that for with Financial place we're into model. our NFS
articles review out published to During with the peer it or clinician’s and second we clinical publications. enter develop we allowed in had These to how articles the offices. stand continue along distinguished quarter SANUWAVE research, we two
They to be today criteria the jury inclusion they Many the to studies a tend make aren't good, loved ulcer compliant. fact to but foot results exact. that they are XXX have life with that patients, we rig, they wound smoke, study they diabetic real and look their and do performed life that exclusion real-world sure in real patients, overweight
our patients clinical peer So results and articles us first will world there in improve what and step research us and outcomes out stand this the reflects real our review usage study. are in door. study are XXX the allows to keep and Patient This getting the with rates.
a Also, we're us. the referrals word using clinicians mouth that to of beginning from are lot of get coming to us
plan continue in the place for leverage research Our approvals. and and invest add broader to indications is to
dermaPACE for guarantee news path National at NGS, change a is it Services, Medicare. front. This to easier, we to biggest long accepted, it an we reimbursement appeal the coverage be submit is on policy The Government claim, announced in we a potentially go-through a reimbursement extremely allow change not really with Yesterday, XX category reimbursement. to denied a clearer states. comfortable before receive policy in feel The be laborious for will that's are where then moves be would claim how approaching a will but process. up The process
adding and claim that commission this region. are a in additional a this under determined strong based clinician in a NGS DFU than is be managers have be they submits likely a to when this that Since support protocol, very on to we use care clinical – we standard necessity. of when clinical change change way It each better approved. sales have The to heal a to statistically allows we're individual shows due
growing from We this Pennsylvania. does won't or expect That Carolina of area Texas procedures come mean the mix to QX XXXX. in be our and in a we not or
in today. quickly. The we more to fact, claims placements change processed seeing to allows already in us areas In revenue are those moving accelerate reimbursement
an in evaluation. days XX spend would placements initial Our
and revenue recognition go-forward move means which a eliminating today, on as change earlier we moving phase the we to basis. With that forward, evaluation contracts are straight
larger QX we of percentage revenue will to from come the revenue procedures. expect During will then we our initial begin and a in procedures see from QX
remember we Our average $XXX to refine XXXX, throughout to than procedures, we'll It's $XXX expected. lead between as of standpoint placements strong just allow with and procedure. being faster go incremental still procedures break lead the expectation them out remainder worked to and also should revenue. but get out are This even originally will margins. we highly per to recurring us a These is
even provide break We expect before to the of guidance year. on the end
exclusive it was to than due below payments year second of payments. was exclusive $XXX,XXX higher XXXX. license were revenue – The timing license in last In quarter XXXX,
and fees before, have we procedural be least do mentioned a third one in will have We XX revenue over already I've played tend but to to which exist. up we positive the or of quarter, at we the – continue context. two exclusivity As and Until and placed these lumpy. have to get lumpiness stream expect devices will international fees end already orders the before in year exclusivity shipping lumpiness, cause running,
to XXXX turn out, and six one have with first I be the but wish we minute, over pronouncements. then we'll a Q&A. will smooth and I will to accounting under could goals and discussing recognized spend they Lisa – for can't, months, then they our conclude accomplishments I it certain our to them for happen Shri
for on repeat on to patients treatment. forward. I earlier, we XXXX, And At the for goals certified, and XXX Over least track pay we're track devices clinicians mentioned XXX our placed, insurance lives for will well are $X XX million million, that are we're which there. NGS on that's covered as that. so with way Our those
goal Add of that's three to address Shri half in four personnel additional targeting an currently. clinical science ongoing exceed advisors will we're trials, Our coming function, to the already. new that second number. launch to we the and started people countries, is that will three the and some two key we've that's Add
placed have well over and achieving provide we achieve million are way all past, to plan X,XXX devices in discussed that, on in over everywhere well that We grand is successful our in are in If anywhere which the years. part these a four next device we treated. DFU and is is a the goals our will we revenue have of $XXX which to
also other other indications other this timeline, companies for need investor our in treating with wound so with treatment along we we a to it in work we with the and wounds add presentation will milestones measure shareholders how conjunction on time, are progressing way. the modalities. out Over We've on can achieve laid
some our President, discussion some financials. Parikh, will Shri will by share about from followed to who will review over Lisa, the it more conclude with who I And field insights then Shri? turn XXXX. me Let